Cargando…
Development of Praziquantel sulphonamide derivatives as antischistosomal drugs
The almost empty armamentarium to treat schistosomiasis, a neglected parasitic disorder caused by trematode flatworms of the genus Schistosoma, except Praziquantel (PZQ), urged to find new alternatives to fight this infection. Carbonic Anhydrase from Schistosoma mansoni (SmCA) is a possible new targ...
Autores principales: | Angeli, Andrea, Ferraroni, Marta, Carta, Fabrizio, Häberli, Cécile, Keiser, Jennifer, Costantino, Gabriele, Supuran, Claudiu T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9154761/ https://www.ncbi.nlm.nih.gov/pubmed/35635137 http://dx.doi.org/10.1080/14756366.2022.2078970 |
Ejemplares similares
-
An Artemisinin Derivative of Praziquantel as an Orally Active Antischistosomal Agent
por: Dong, Lanlan, et al.
Publicado: (2014) -
In Vitro Antileishmanial and Antischistosomal Activities of Anemonin Isolated from the Fresh Leaves of Ranunculus multifidus Forsk
por: Sirak, Betelhem, et al.
Publicado: (2021) -
Selenocarbamates As a Prodrug‐Based Approach to Carbonic Anhydrase Inhibition
por: Angeli, Andrea, et al.
Publicado: (2022) -
In vitro and in vivo antischistosomal activity of ferroquine derivatives
por: Keiser, Jennifer, et al.
Publicado: (2014) -
Design, Synthesis and Evaluation of Praziquantel Analogues and New Molecular Hybrids as Potential Antimalarial and Anti-Schistosomal Agents
por: Kasago, Freddy Mugisho, et al.
Publicado: (2023)